Global Oral Migraine Drugs Production, Demand and Key Producers, 2022-2028

December 2022 | 102 pages | ID: G2FC4E12B27AEN
GlobalInfoResearch

Abstracts

This report studies the global Oral Migraine Drugs demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Oral Migraine Drugs, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Oral Migraine Drugs that contribute to its increasing demand across many markets.

The global Oral Migraine Drugs market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).

Highlights and key features of the study

Global Oral Migraine Drugs total market, 2017-2028, (USD Million)

Global Oral Migraine Drugs total market by region & country, CAGR, 2017-2028, (USD Million)

U.S. VS China: Oral Migraine Drugs total market, key domestic companies and share, (USD Million)

Global Oral Migraine Drugs revenue by player and market share 2017-2022, (USD Million)

Global Oral Migraine Drugs total market by Type, CAGR, 2017-2028, (USD Million)

Global Oral Migraine Drugs total market by Application, CAGR, 2017-2028, (USD Million)

This reports profiles major players in the global Oral Migraine Drugs market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, Teva, Pfizer, Novartis, Sun Pharma, Grunenthal, Endo Pharmaceuticals, Merck and J & J, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Oral Migraine Drugs market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.

Global Oral Migraine Drugs Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India
• Rest of World

Global Oral Migraine Drugs Market, Segmentation by Type

• Prescription Drug
• OTC Drug

Global Oral Migraine Drugs Market, Segmentation by Application

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Companies Profiled:

• GSK
• Teva
• Pfizer
• Novartis
• Sun Pharma
• Grunenthal
• Endo Pharmaceuticals
• Merck
• J & J

Key Questions Answered

1. How big is the global Oral Migraine Drugs market?

2. What is the demand of the global Oral Migraine Drugs market?

3. What is the year over year growth of the global Oral Migraine Drugs market?

4. What is the total value of the global Oral Migraine Drugs market?

5. Who are the major players in the global Oral Migraine Drugs market?

6. What are the growth factors driving the market demand?

Contents

1 SUPPLY SUMMARY

1.1 Oral Migraine Drugs Introduction
1.2 World Oral Migraine Drugs Market Size & Forecast (2017 & 2021 & 2028)
1.3 World Oral Migraine Drugs Total Market by Region
  1.3.1 World Oral Migraine Drugs Market Size by Region (2017-2028)
  1.3.2 United States Oral Migraine Drugs Market Size (2017-2028)
  1.3.3 China Oral Migraine Drugs Market Size (2017-2028)
  1.3.4 Europe Oral Migraine Drugs Market Size (2017-2028)
  1.3.5 Japan Oral Migraine Drugs Market Size (2017-2028)
  1.3.6 South Korea Oral Migraine Drugs Market Size (2017-2028)
  1.3.7 ASEAN Oral Migraine Drugs Market Size (2017-2028)
  1.3.8 India Oral Migraine Drugs Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Oral Migraine Drugs Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Oral Migraine Drugs Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 WORLD ORAL MIGRAINE DRUGS COMPANIES COMPETITIVE ANALYSIS

2.1 World Oral Migraine Drugs Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
  2.2.1 Global Oral Migraine Drugs Industry Rank of Major Players
  2.2.2 Global Concentration Ratios (CR4) for Oral Migraine Drugs in 2021
  2.2.3 Global Concentration Ratios (CR8) for Oral Migraine Drugs in 2021
2.3 Oral Migraine Drugs Company Evaluation Quadrant
2.4 Oral Migraine Drugs Market: Overall Company Footprint Analysis
  2.4.1 Oral Migraine Drugs Market: Region Footprint
  2.4.2 Oral Migraine Drugs Market: Company Product Type Footprint
  2.4.3 Oral Migraine Drugs Market: Company Product Application Footprint
2.5 Competitive Environment
  2.5.1 Historical Structure of the Industry
  2.5.2 Barriers of Market Entry
  2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity

3 UNITED STATES VS CHINA VS REST OF THE WORLD

3.1 United States VS China: Oral Migraine Drugs Market Comparison
  3.1.1 United States VS China: Oral Migraine Drugs Market Size Comparison (2017 & 2021 & 2028)
  3.1.2 United States VS China: Oral Migraine Drugs Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States Oral Migraine Drugs Major Players and Market Share, 2017-2022
  3.2.1 Major Players of Oral Migraine Drugs in United States, Headquarters (States, Country)
  3.2.2 United States Oral Migraine Drugs Revenue by Domestic Player, (2017-2022)
3.3 China Oral Migraine Drugs Major Players and Market Share, 2017-2022
  3.3.1 Major Players of Oral Migraine Drugs in China, Headquarters (Province, Country)
  3.3.2 China Oral Migraine Drugs Revenue by Domestic Player, (2017-2022)
3.4 Rest of World Oral Migraine Drugs Major Players and Market Share, 2017-2022
  3.4.1 Major Players of Oral Migraine Drugs in Rest of World, Headquarters (State, Country)
  3.4.2 Rest of World Oral Migraine Drugs Revenue by Domestic Player, (2017-2022)

4 MARKET ANALYSIS BY TYPE

4.1 World Oral Migraine Drugs Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
  4.2.1 Prescription Drug
  4.2.2 OTC Drug
4.3 Market Segment by Type
  4.3.1 World Oral Migraine Drugs Market Size by Type (2017-2022)
  4.3.2 World Oral Migraine Drugs Market Size by Type (2023-2028)
  4.3.3 World Oral Migraine Drugs Market Size Market Share by Type (2017-2028)

5 MARKET ANALYSIS BY APPLICATION

5.1 World Oral Migraine Drugs Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
  5.2.1 Hospital Pharmacy
  5.2.2 Retail Pharmacy
  5.2.3 Online Pharmacy
5.3 Market Segment by Application
  5.3.1 World Oral Migraine Drugs Market Size by Application (2017-2022)
  5.3.2 World Oral Migraine Drugs Market Size by Application (2023-2028)
  5.3.3 World Oral Migraine Drugs Market Size by Application (2017-2028)

6 COMPANY PROFILES

6.1 GSK
  6.1.1 GSK Details
  6.1.2 GSK Major Business
  6.1.3 GSK Oral Migraine Drugs Product and Services
  6.1.4 GSK Oral Migraine Drugs Revenue, Gross Margin and Market Share (2017-2022)
  6.1.5 GSK Recent Developments/Updates
  6.1.6 GSK Competitive Strengths & Weaknesses
6.2 Teva
  6.2.1 Teva Details
  6.2.2 Teva Major Business
  6.2.3 Teva Oral Migraine Drugs Product and Services
  6.2.4 Teva Oral Migraine Drugs Revenue, Gross Margin and Market Share (2017-2022)
  6.2.5 Teva Recent Developments/Updates
  6.2.6 Teva Competitive Strengths & Weaknesses
6.3 Pfizer
  6.3.1 Pfizer Details
  6.3.2 Pfizer Major Business
  6.3.3 Pfizer Oral Migraine Drugs Product and Services
  6.3.4 Pfizer Oral Migraine Drugs Revenue, Gross Margin and Market Share (2017-2022)
  6.3.5 Pfizer Recent Developments/Updates
  6.3.6 Pfizer Competitive Strengths & Weaknesses
6.4 Novartis
  6.4.1 Novartis Details
  6.4.2 Novartis Major Business
  6.4.3 Novartis Oral Migraine Drugs Product and Services
  6.4.4 Novartis Oral Migraine Drugs Revenue, Gross Margin and Market Share (2017-2022)
  6.4.5 Novartis Recent Developments/Updates
  6.4.6 Novartis Competitive Strengths & Weaknesses
6.5 Sun Pharma
  6.5.1 Sun Pharma Details
  6.5.2 Sun Pharma Major Business
  6.5.3 Sun Pharma Oral Migraine Drugs Product and Services
  6.5.4 Sun Pharma Oral Migraine Drugs Revenue, Gross Margin and Market Share (2017-2022)
  6.5.5 Sun Pharma Recent Developments/Updates
  6.5.6 Sun Pharma Competitive Strengths & Weaknesses
6.6 Grunenthal
  6.6.1 Grunenthal Details
  6.6.2 Grunenthal Major Business
  6.6.3 Grunenthal Oral Migraine Drugs Product and Services
  6.6.4 Grunenthal Oral Migraine Drugs Revenue, Gross Margin and Market Share (2017-2022)
  6.6.5 Grunenthal Recent Developments/Updates
  6.6.6 Grunenthal Competitive Strengths & Weaknesses
6.7 Endo Pharmaceuticals
  6.7.1 Endo Pharmaceuticals Details
  6.7.2 Endo Pharmaceuticals Major Business
  6.7.3 Endo Pharmaceuticals Oral Migraine Drugs Product and Services
  6.7.4 Endo Pharmaceuticals Oral Migraine Drugs Revenue, Gross Margin and Market Share (2017-2022)
  6.7.5 Endo Pharmaceuticals Recent Developments/Updates
  6.7.6 Endo Pharmaceuticals Competitive Strengths & Weaknesses
6.8 Merck
  6.8.1 Merck Details
  6.8.2 Merck Major Business
  6.8.3 Merck Oral Migraine Drugs Product and Services
  6.8.4 Merck Oral Migraine Drugs Revenue, Gross Margin and Market Share (2017-2022)
  6.8.5 Merck Recent Developments/Updates
  6.8.6 Merck Competitive Strengths & Weaknesses
6.9 J & J
  6.9.1 J & J Details
  6.9.2 J & J Major Business
  6.9.3 J & J Oral Migraine Drugs Product and Services
  6.9.4 J & J Oral Migraine Drugs Revenue, Gross Margin and Market Share (2017-2022)
  6.9.5 J & J Recent Developments/Updates
  6.9.6 J & J Competitive Strengths & Weaknesses

7 RAW MATERIAL AND INDUSTRY CHAIN

7.1 Raw Material of Oral Migraine Drugs and Key Manufacturers
7.2 Oral Migraine Drugs Manufacturing Costs
7.3 Oral Migraine Drugs Production Process
7.4 Oral Migraine Drugs Industrial Chain

8 DISTRIBUTION CHANNEL ANALYSIS

8.1 Distribution Channel Breakdown for Oral Migraine Drugs Shipments (%): 2017-2028
  8.1.1 Direct Channel
  8.1.2 Indirect Channel
8.2 Oral Migraine Drugs Typical Distributors
8.3 Oral Migraine Drugs Typical Customers

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World Oral Migraine Drugs Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Oral Migraine Drugs Market Size by Region (2017-2022) & (USD Million)
Table 3. World Oral Migraine Drugs Market Size by Region (2023-2028) & (USD Million)
Table 4. World Oral Migraine Drugs Market Size Market Share by Region (2017-2022)
Table 5. World Oral Migraine Drugs Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World Oral Migraine Drugs Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key Oral Migraine Drugs Players in 2021
Table 9. World Oral Migraine Drugs Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global Oral Migraine Drugs Company Evaluation Quadrant
Table 11. Head Office of Key Oral Migraine Drugs Player
Table 12. Oral Migraine Drugs Market: Company Product Type Footprint
Table 13. Oral Migraine Drugs Market: Company Product Application Footprint
Table 14. Oral Migraine Drugs Mergers & Acquisitions Activity
Table 15. United States VS China Oral Migraine Drugs Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of Oral Migraine Drugs in United States, Headquarters (States, Country)
Table 17. United States Oral Migraine Drugs Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States Oral Migraine Drugs Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of Oral Migraine Drugs in China, Company Headquarters (Province, Country)
Table 20. China Oral Migraine Drugs Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China Oral Migraine Drugs Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of Oral Migraine Drugs in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World Oral Migraine Drugs Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World Oral Migraine Drugs Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World Oral Migraine Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World Oral Migraine Drugs Revenue by Type (2017-2022) & (USD Million)
Table 27. World Oral Migraine Drugs Revenue by Type (2023-2028) & (USD Million)
Table 28. World Oral Migraine Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World Oral Migraine Drugs Revenue by Application (2017-2022) & (USD Million)
Table 30. World Oral Migraine Drugs Revenue by Application (2023-2028) & (USD Million)
Table 31. GSK Basic Information, Area Served and Competitors
Table 32. GSK Major Business
Table 33. GSK Oral Migraine Drugs Product and Services
Table 34. GSK Oral Migraine Drugs Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. GSK Recent Developments/Updates
Table 36. GSK Competitive Strengths & Weaknesses
Table 37. Teva Basic Information, Area Served and Competitors
Table 38. Teva Major Business
Table 39. Teva Oral Migraine Drugs Product and Services
Table 40. Teva Oral Migraine Drugs Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. Teva Recent Developments/Updates
Table 42. Teva Competitive Strengths & Weaknesses
Table 43. Pfizer Basic Information, Area Served and Competitors
Table 44. Pfizer Major Business
Table 45. Pfizer Oral Migraine Drugs Product and Services
Table 46. Pfizer Oral Migraine Drugs Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. Pfizer Recent Developments/Updates
Table 48. Pfizer Competitive Strengths & Weaknesses
Table 49. Novartis Basic Information, Area Served and Competitors
Table 50. Novartis Major Business
Table 51. Novartis Oral Migraine Drugs Product and Services
Table 52. Novartis Oral Migraine Drugs Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. Novartis Recent Developments/Updates
Table 54. Novartis Competitive Strengths & Weaknesses
Table 55. Sun Pharma Basic Information, Area Served and Competitors
Table 56. Sun Pharma Major Business
Table 57. Sun Pharma Oral Migraine Drugs Product and Services
Table 58. Sun Pharma Oral Migraine Drugs Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. Sun Pharma Recent Developments/Updates
Table 60. Sun Pharma Competitive Strengths & Weaknesses
Table 61. Grunenthal Basic Information, Area Served and Competitors
Table 62. Grunenthal Major Business
Table 63. Grunenthal Oral Migraine Drugs Product and Services
Table 64. Grunenthal Oral Migraine Drugs Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. Grunenthal Recent Developments/Updates
Table 66. Grunenthal Competitive Strengths & Weaknesses
Table 67. Endo Pharmaceuticals Basic Information, Area Served and Competitors
Table 68. Endo Pharmaceuticals Major Business
Table 69. Endo Pharmaceuticals Oral Migraine Drugs Product and Services
Table 70. Endo Pharmaceuticals Oral Migraine Drugs Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. Endo Pharmaceuticals Recent Developments/Updates
Table 72. Endo Pharmaceuticals Competitive Strengths & Weaknesses
Table 73. Merck Basic Information, Area Served and Competitors
Table 74. Merck Major Business
Table 75. Merck Oral Migraine Drugs Product and Services
Table 76. Merck Oral Migraine Drugs Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. Merck Recent Developments/Updates
Table 78. J & J Basic Information, Area Served and Competitors
Table 79. J & J Major Business
Table 80. J & J Oral Migraine Drugs Product and Services
Table 81. J & J Oral Migraine Drugs Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 82. Oral Migraine Drugs Raw Material
Table 83. Key Manufacturers of Oral Migraine Drugs Raw Materials
Table 84. Oral Migraine Drugs Typical Distributors
Table 85. Oral Migraine Drugs Typical Customers

List Of Figures

LIST OF FIGURES

Figure 1. Oral Migraine Drugs Picture
Figure 2. World Oral Migraine Drugs Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Oral Migraine Drugs Total Market Size (2017-2028) & (USD Million)
Figure 4. World Oral Migraine Drugs Market Size Market Share by Region (2017-2028)
Figure 5. United States Oral Migraine Drugs Market Size (2017-2028) & (USD Million)
Figure 6. China Oral Migraine Drugs Market Size (2017-2028) & (USD Million)
Figure 7. Europe Oral Migraine Drugs Market Size (2017-2028) & (USD Million)
Figure 8. Japan Oral Migraine Drugs Market Size (2017-2028) & (USD Million)
Figure 9. South Korea Oral Migraine Drugs Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN Oral Migraine Drugs Market Size (2017-2028) & (USD Million)
Figure 11. India Oral Migraine Drugs Market Size (2017-2028) & (USD Million)
Figure 12. Oral Migraine Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of Oral Migraine Drugs by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for Oral Migraine Drugs Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for Oral Migraine Drugs Markets in 2021
Figure 17. United States VS China: Oral Migraine Drugs Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World Oral Migraine Drugs Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World Oral Migraine Drugs Market Size Market Share by Type in 2021
Figure 20. Prescription Drug
Figure 21. OTC Drug
Figure 22. World Oral Migraine Drugs Market Size Market Share by Type (2017-2028)
Figure 23. World Oral Migraine Drugs Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 24. World Oral Migraine Drugs Market Size Market Share by Application in 2021
Figure 25. Hospital Pharmacy
Figure 26. Retail Pharmacy
Figure 27. Online Pharmacy
Figure 28. World Oral Migraine Drugs Market Size Market Share by Application (2017-2028)
Figure 29. Manufacturing Cost Structure Analysis of Oral Migraine Drugs in 2021
Figure 30. Manufacturing Process Analysis of Oral Migraine Drugs
Figure 31. Oral Migraine Drugs Industrial Chain
Figure 32. Distribution Channel Breakdown for Oral Migraine Drugs Shipments (%): 2017-2028
Figure 33. Direct Channel Pros & Cons
Figure 34. Indirect Channel Pros & Cons
Figure 35. Methodology
Figure 36. Research Process and Data Source